Amaryl M 2 mg+500 mg (Tablet (Prolonged Release))
Unit Price: ৳ 18.00 (3 x 10: ৳ 540.00)
Strip Price: ৳ 180.00
Medicine Details
Category | Details |
---|---|
Generic | Glimepiride metformin |
Company | Synovia pharma plc |
Also available as |
Therapeutic Class
- Combination Oral hypoglycemic preparations
Indications
- Adjunct to diet and exercise in type 2 diabetes mellitus patients
- Monotherapy with glimepiride or metformin not resulting in adequate glycemic control
- Replacement of combination therapy of glimepiride and metformin
Pharmacology
- Glimepiride: Sulfonylurea antidiabetic agent
- Stimulates release of insulin from pancreatic beta cells
- Improves sensitivity of beta cells to glucose stimulus
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin and glucose uptake
- Metformin Hydrochloride: Biguanide type oral antihyperglycemic drug
- Lowers both basal and postprandial plasma glucose
- Improves insulin sensitivity
- Decreases hepatic glucose production
- Decreases intestinal absorption of glucose
Dosage
- Governing factor is desired blood glucose level
- Must be the lowest sufficient to achieve desired metabolic control
- Glucose levels in blood and urine must be measured regularly
- Timely dose reduction or cessation of therapy must be considered to avoid hypoglycemia
- Highest recommended dose per day: 8 mg of glimepiride and 2000 mg of metformin
Administration
- Tablet must be swallowed whole and not crushed or chewed
Interaction
- Glimepiride: Metabolized by cytochrome P450 2C9 (CYP2C9)
- Potentiation of blood-glucose-lowering effect and hypoglycemia with certain drugs
- Weakening of blood-glucose-lowering effect and raised blood glucose levels with certain drugs
- Acute and chronic alcohol intake may potentiate or weaken the blood-glucose-lowering action in an unpredictable fashion
- Metformin: Concomitant use not recommended with alcohol, iodinated contrast agents, and combinations requiring precautions for use
Contraindications
- Hypersensitivity to glimepiride, metformin, sulfonylureas, sulfonamides, or any excipients
- Pregnancy, breastfeeding
- Severe impairment of liver function, dialysis, acute metabolic acidosis, severe renal failure, renal dysfunction, acute conditions altering renal function, tissue hypoxia, hepatic insufficiency, acute alcohol intoxication, alcoholism
Side Effects
- Hypoglycemia, prolonged hypoglycemia, temporary visual impairment, gastrointestinal symptoms, hepatitis, elevation of liver enzyme levels, cholestasis, jaundice, blood disorders, alopecia, allergic or pseudo allergic reactions, decrease in serum sodium concentration, weight gain
- Gastrointestinal symptoms, metallic taste, decrease of vitamin B12 absorption, lactic acidosis, hemolytic anemia, reduction of thyrotropin level, hypomagnesemia, encephalopathy, photosensitivity, hepatobiliary disorders
Pregnancy & Lactation
- Glimepiride: Must not be taken during pregnancy, change over to insulin recommended
- Metformin: Diabetes should not be treated with metformin during pregnancy, insulin should be used to maintain blood glucose levels as close to normal as possible
- Glimepiride: Must not be taken by breastfeeding women, change over to insulin recommended
- Metformin: Excreted into milk in lactating rats, decision should be made whether to discontinue nursing or metformin
Precautions & Warnings
- Initial weeks of treatment, risk of hypoglycemia may be increased
- Severe hypoglycemia requires immediate treatment and follow-up by a physician
- Caution in patients with G6PD-deficiency, non-sulfonylurea alternative should be considered
- Regular monitoring of TSH levels in patients with hypothyroidism
- Long-term treatment associated with decrease in vitamin B12 serum levels, monitoring recommended
Use in Special Populations
- Insufficient data to recommend pediatric use
- Renal impairment: Assessment of GFR before initiation of treatment, GFR should be assessed annually, maximum daily dose of metformin should be divided into 2-3 daily doses, metformin contraindicated in GFR <30 mL/min
Overdose Effects
- Acute overdosage or treatment with too high a dose of glimepiride may lead to severe hypoglycemia
- Hypoglycemia not seen with metformin doses up to 85 g, lactic acidosis occurred in such circumstances, treatment in hospital necessary
- Pancreatitis may occur in the context of a metformin overdose
Storage Conditions
- Store in a cool and dry place, protected from light
Related Brands
- Redimat 2 mg+500 mg (Tablet (Extended Release)) - radius-pharmaceuticals-ltd
- Glims M XR 2 mg+500 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- Glims M XR 1 mg+500 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- Limpet M 1 mg+500 mg (Tablet (Extended Release)) - drug-international-ltd
- Limpet M 2 mg+500 mg (Tablet (Extended Release)) - drug-international-ltd